Parallel-group, placebo-controlled study to evaluate the safety, tolerability, and efficacy of repeated intravenous administration of S-005151 to patients with ischemic cardiomyopathy undergoing coronary artery bypass surgery (Phase I/II)

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2024
This article has no abstract
Epistemonikos ID: f3e318c7109feea6e6d67388565df434f3ac0ace
First added on: Apr 11, 2025